logo
Abu Dhabi to welcome top-tier physicians from US, South Korea, Australia this July

Abu Dhabi to welcome top-tier physicians from US, South Korea, Australia this July

Al Etihad2 days ago
7 July 2025 00:59
SAMIHAH ZAMAN (ABU DHABI)Abu Dhabi will once again welcome several leading physicians in a bid to offer expert healthcare and medical services within the emirate.Coming to Abu Dhabi as part of the Department of Health- Abu Dhabi (DoH) Visiting Physicians Programme , the doctors will provide medical care and advice in plastic surgery, paediatric oncology, ophthalmology, and spine care.'The DoH welcomes top-tier doctors from around the world to the Emirate during July, offering exceptional healthcare services through the Visiting Physicians Programme,' the DoH announced on its social media platforms.Dr. Michael Grimley, paediatric haematologist-oncologist at Cincinnati Children's Hospital, US, is one of the quartet of doctors heading to the UAE capital this month. Dr. Grimley specialises in the care of anaemia, sickle cell disease, haemophilia, leukaemia, and lymphoma. He will see patients at the Sheikh Khalifa Medical City between July 7-11, 2025.Paul Geelen, ocularist at the Artificial Eye Services Hospital in Perth, Australia, will see patients at Moorfields Eye Hospital between July 13 -17, 2025. Geelen has more than two decades of experience in the making and fitting of hand crafted artificial eyes.Dr. Zeeshan Sardar, associate chief of spine and scoliosis surgery at the New York Presbyterian Hospital, US, will meanwhile be available at Healthpoint Hospital between July 28 and August 1, 2025. Dr. Sardar is an expert in the treatment of adult scoliosis, ankylosing spondylitis, complex spine surgery, and degenerative spine diseases.Dr. Joon Pio Hong, consultant plastic surgeon at Asan Medical Center, South Korea, has also offered medical care for lymphoedema, lipoedema, and diabetic foot at Abu Dhabi's Tarmeem Hospital and Healthpoint Hospital this July.The DoH has urged patients and their families to book appointments with the experts by contacting the respective health care facilities.Launched in 2021 with the aim of providing top-notch healthcare within Abu Dhabi, the Visiting Physicians Programme has enabled more than 300 surgeries, and seen the contribution of more than 30 visiting experts from around the world.
As of December 2024, more than 3,200 patients had received treatment and consultation in Abu Dhabi as part of the initiative.
Source: Aletihad - Abu Dhabi
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Yas Clinic launches advanced robotic spine surgery programme
Yas Clinic launches advanced robotic spine surgery programme

Zawya

time4 hours ago

  • Zawya

Yas Clinic launches advanced robotic spine surgery programme

Yas Clinic Khalifa City, in collaboration with the Abu Dhabi Stem Cells Centre, has launched an advanced robotic spine surgery programme that uses an intelligent navigation system powered by artificial intelligence, marking a significant step forward in establishing Abu Dhabi as a leading hub for advanced medical care. The launch follows the successful completion of two complex procedures by the medical team on female patients in their fifties and sixties who were suffering from spinal canal stenosis and chronic pain that had impaired their mobility. The precision of the robotic intervention accelerated the patients' recovery and enabled them to return to their normal lives. Dr. Maysoon Al Karam, Chief Medical Officer at the hospital, said the technology represents a breakthrough in minimally invasive surgery, enabling unprecedented levels of precision and safety while significantly reducing potential risks. Professor Amr El-Shawarbi, Consultant Neurosurgeon, said the system constitutes a revolution in spinal surgery by providing complete control and extreme accuracy, offering patients better prospects for safe and rapid recovery. The launch is part of the hospital's strategy to integrate cutting-edge medical solutions and expand the scope of robotic surgery to include other specialties in the future, reinforcing Abu Dhabi's position as a regional destination for advanced surgical procedures.

Cleveland Clinic Abu Dhabi performs first robotic lung transplant in the gulf region
Cleveland Clinic Abu Dhabi performs first robotic lung transplant in the gulf region

Zawya

time6 hours ago

  • Zawya

Cleveland Clinic Abu Dhabi performs first robotic lung transplant in the gulf region

Cleveland Clinic Abu Dhabi's lung transplant team continues to push the envelope of surgical innovation, providing patients the latest in surgical care. Cleveland Clinic Abu Dhabi has performed more than 60 lung transplants since 2022. Abu Dhabi, United Arab Emirates: Cleveland Clinic Abu Dhabi has made history by performing the Gulf region's first-ever robotic lung transplant making it one of the five centers in the world to have performed this surgery. With this landmark complex surgery, two patients have now successfully undergone robotic lung transplants, marking a major milestone in the region's advanced surgical and organ transplant capabilities. Both patients had idiopathic pulmonary fibrosis (IPF) as well as secondary pulmonary hypertension, a progressive condition that gradually scars the lungs and makes breathing increasingly difficult. Dr. Usman Ahmad, Chair of Thoracic Surgery, performed the complex robotic procedures along with a multi-disciplinary team of experts, including Drs. Yusuf Bayrak, Andres Obeso, Binu Esaw, Arun Kumar, and pulmonary experts including Drs. Fadi Hamed, Said Isse and Miriam Mihalechkova. These surgeries were quite complex due to pulmonary hypertension, a condition that puts extra strain on the heart and lungs. To support the patients during the operation, the medical team used Veno-Arterial ECMO, a technique that temporarily takes over the work of the heart and lungs while the damaged lungs are replaced. These life-saving surgeries would not have been possible without the extraordinary generosity of organ donor families, whose selfless gifts make such transplants possible. The hospital also acknowledges the critical role played by healthcare professionals from donor hospitals, the National Program for Organ Donation and Transplantation – HAYAT, the Department of Health- Abu Dhabi, and the National Center at the Ministry of Health and Prevention (MOHAP). Their collective efforts form the foundation of the UAE's organ donation and transplantation ecosystem and are vital to every success in this field. Recognizing their contributions honors the spirit of collaboration, compassion, and national progress that makes these achievements possible. Dr. Georges-Pascal Haber, Chief Executive Officer of Cleveland Clinic Abu Dhabi, said: 'At Cleveland Clinic Abu Dhabi, we're proud to be global pioneers in robotic surgery, advancing the field of robotic transplantation and bringing new hope to patients in need. Being one of only a handful of centers in the world capable of performing these procedures reflects the exceptional skill, talent, and world-class expertise we have at Cleveland Clinic Abu Dhabi. It also reinforces Abu Dhabi's position as a global hub for healthcare innovation.' Robotic-assisted surgery is rarely used in lung transplantation due to its complexity, however the surgical team's proven proficiency in performing advanced robotic procedures made it a viable option in these cases. Their expertise enabled them to carry out the transplant through smaller incisions, enhancing surgical precision, reducing recovery time, and minimizing pain and complications, even in such high-risk cases. This minimally invasive procedure represents the next generation of thoracic surgery offering hope to patients who may be considered too frail for traditional open surgery. Dr. Usman Ahmad, Division Chair, Thoracic Surgery at Cleveland Clinic Abu Dhabi, said: 'Performing a robotic-assisted lung transplant requires not just the surgical expertise, but more importantly a fully integrated ecosystem of advanced technology, expert anesthesia support, and meticulous perfusion management. In these cases, the robotic approach was chosen due to its minimally invasive nature, which can be particularly beneficial for patients with severe frailty. By using smaller incisions and offering enhanced visualization, the robotic platform allowed us to reduce trauma to the chest, minimize bleeding, and accelerate recovery. This was one of the most complex operations we've ever undertaken, a high-stakes, high-reward scenario and it stands as a profound achievement not only for Cleveland Clinic Abu Dhabi, but for the UAE in its evolution in complex surgical care.' The success of these procedures was made possible by a seamlessly coordinated, multidisciplinary effort that extended well beyond the operating room. From pre-surgical planning to post-transplant care, teams across surgery, anesthesia, and critical care worked together to ensure the best possible outcomes. Building on that, Dr. Fadi Hamed, Staff Physician, Critical Care, Integrated Hospital Care Institute, said: 'What sets Cleveland Clinic Abu Dhabi's Lung Transplant Program apart is our ability to offer timely, high-quality care in a region where such advanced procedures were once considered out of reach, with success rates matching international benchmarks. Our patients benefit from significantly shorter wait times, access to size-matched donor organs through our integrated transplant network, and minimal ischemic time, which directly improves outcomes. In addition, our dedicated lung transplant and critical care teams, many of whom have undergone specialized training, work in perfect synergy to ensure patients receive the most cutting-edge, personalized care available. This level of coordination and innovation has truly positioned us as a regional leader in lung transplantation.' Further solidifying its leadership in regional transplant medicine, Cleveland Clinic Abu Dhabi has surpassed a significant milestone this year, completing over 60 lung transplants since the relaunch of the program in 2022, establishing itself as the most advanced and active center of its kind in the region. These cases exemplify the program's potential and underscores Cleveland Clinic Abu Dhabi's emergence as a global referral hub for patients with end-stage lung disease, including complex conditions such as Chronic Obstructive Pulmonary Disease as well as Interstitial Lung Disease, Cystic Fibrosis, Pulmonary Hypertension, and Bronchiectasis. To learn more about Cleveland Clinic Abu Dhabi's Lung Transplant Program, visit: About Cleveland Clinic Abu Dhabi Cleveland Clinic Abu Dhabi is a multispecialty hospital located on Al Maryah Island in Abu Dhabi, UAE. As an extension of Cleveland Clinic in the U.S., it is uniquely designed to address the complex and critical care needs of the UAE and the broader region. The hospital is organized into specialized Institutes, including Heart, Vascular & Thoracic; Neurological; Cancer; Digestive Disease; Medical Subspecialties; Integrated Surgical Subspecialties; Integrated Hospital Care; and Diagnostic. Celebrating its 10th anniversary in 2025, Cleveland Clinic Abu Dhabi is a 405-bed hospital, including 321 acute care beds, 84 critical care beds, four royal suites, and 26 operating rooms. Its state-of-the-art facilities provide patients in the region with direct access to world-class healthcare providers and Cleveland Clinic's renowned model of care. The hospital is also home to the Fatima bint Mubarak Center, a dedicated cancer center offering comprehensive diagnostics and advanced treatment across 24 clinical departments, covering a range of cancer subspecialties and programs. Committed to medical innovation, Cleveland Clinic Abu Dhabi integrates robotics across specialties, pioneers' endovascular therapy and hybrid procedures, and offers comprehensive programs in heart failure, heart transplantation, and limb salvage. Licensed by the Department of Health – Abu Dhabi as a designated research and teaching facility, Cleveland Clinic Abu Dhabi drives medical innovation through clinical trials and advanced research to enhance patient care. It is the first hospital in the UAE accredited by both the Accreditation Council for Graduate Medical Education International (ACGMEI) and the Accreditation Council for Continuing Medical Education (ACCME), offering residency and fellowship programs, undergraduate health professional training, and Continuing Medical Education (CME). M42 is a global, tech-enabled healthcare company based in Abu Dhabi, operating at the forefront of medical advancement. Media contact Farah Chaaban –

Abu Dhabi leads high-level delegation to US, showcasing emirate's global leadership in healthcare innovation
Abu Dhabi leads high-level delegation to US, showcasing emirate's global leadership in healthcare innovation

Al Etihad

time7 hours ago

  • Al Etihad

Abu Dhabi leads high-level delegation to US, showcasing emirate's global leadership in healthcare innovation

8 July 2025 13:10 ABU DHABI (ALETIHAD)Department of Health – Abu Dhabi (DoH) has led a high-level delegation on a strategic mission to the US to strengthen partnerships and showcase Abu Dhabi's excellence in life sciences and precision visit reflected the emirate's global leadership in healthcare innovation and its commitment to international cooperation to advance scientific research, innovation, and ethical medical delegation visited key US cities including Boston, Washington DC, and Philadelphia, in parallel with Abu Dhabi's participation at BIO International Convention 2025, one of the world's foremost biotechnology visit spotlighted the emirate's achievements in AI, digital health, genomics, and clinical research, and showcased Abu Dhabi's Health, Endurance, Longevity and Medicine (HELM) Life Science Cluster, while promoting long-term strategic partnerships with government entities, research institutions, and global Excellency Dr Noura Khamis Al Ghaithi, Undersecretary of DoH, said: 'This mission demonstrated Abu Dhabi's ongoing efforts to cement its position as a global centre of excellence in health and life sciences. We are committed to fostering partnerships that advance healthcare innovation and enhance quality of life, both in the UAE and globally.'The delegation conducted more than 20 strategic meetings and visits with public and private sector leaders across the US, aimed at enhancing knowledge exchange and investment opportunities, and marked the signing of new agreements that will accelerate the adoption of advanced health mission facilitated joint actions between DoH and global organisations set to shape the future of healthcare. These alliances reinforce the Emirate's steadfast dedication to advancing health outcomes through impactful global collaborations, pioneering research and a robust infrastructure that fosters innovation, talent and investment. Key agreements and partnerships were formed with prestigious US-based peers and partners, including the University of California, San Francisco, the Innovative Genomics Institute, Sanofi, Boehringer Ingelheim, Abbott, Aetna International, GEMMABio and Children's National Hospital. These collaborations focus on establishing genome surgery centres, advancing vaccine development and manufacturing, integrating innovative research platforms and localising pharmaceutical production, while also expanding access to US healthcare networks, developing genomics and biotechnology research centres and launching advanced cell and gene therapy programmes for the side-lines of Abu Dhabi's participation at BIO International Convention in Boston, USA, the Department of Health – Abu Dhabi, in collaboration with Johnson & Johnson (J&J) and Sheikh Shakhbout Medical City (SSMC), a flagship hospital in the UAE for serious and complex care and a subsidiary of the PureHealth group, have successfully enabled expedited access to Tremfya®, a next-generation biologic medication for patients with Inflammatory Bowel Disease (IBD). This strategic partnership marks the first availability of the treatment outside the United States, reinforcing Abu Dhabi's position as a as a pioneering destination for healthcare innovation and advanced, patient-focused Abu Dhabi's innovation ecosystem, the delegation included key stakeholders such as Abu Dhabi Investment Office, Mubadala BIO, M42, Masdar City, KEZAD Group, PureHealth, StartAD, Khalifa University, New York University Abu Dhabi, and Etihad Dhabi continues to lead the region in genomics through the Emirati Genome Programme, which has successfully sequenced more than 800,000 samples, creating one of the most advanced national genomic databases. The emirate is also home to more than 90 licensed research centres and over 30 ongoing clinical trials in areas such as oncology, rare diseases, and chronic data platforms such as Malaffi, which securely store over 5 million patient records—enable AI-powered insights and real-world evidence, while national initiatives like the Golden Visa have enabled more than 2,000 long-term visas for researchers and healthcare professionals from around the world. This strategic visit reflected Abu Dhabi's broader vision for healthcare transformation—driven by innovation, investment, and a deep commitment to global collaboration.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store